Concepedia

Peiwei Yang

PY

12

Publications

635

Citations

12

H-Index

2018

Active since

Affiliations

China Pharmaceutical University(Current)

Nanjing Medical University

Yueyang Hospital

Shanghai University of Traditional Chinese Medicine

Shanghai University

Peiwei Yang is an author at China Pharmaceutical University specializing in medicine, immunotherapy, and immunology.

ORCID

Top concepts

Publications per year

2018–2023

12

Publications

12

Recombination of a dual-CAR-modified T lymphocyte to accurately eliminate pancreatic malignancy

Erhao Zhang, Peiwei Yang, Jieyi Gu et al. · Journal of Hematology & Oncology · 2018 · 105 citations · Full text

, , +9

Natural killer cell-derived exosomal miR-1249-3p attenuates insulin resistance and inflammation in mouse models of type 2 diabetes

Ying Wang, Mengwei Li, Lin Chen et al. · Signal Transduction and Targeted Therapy · 2021 · 86 citations · Full text

Significantly increased anti‐tumor activity of carcinoembryonic antigen‐specific chimeric antigen receptor T cells in combination with recombinant human IL‐12

Xiaowei Chi, Peiwei Yang, Erhao Zhang et al. · Cancer Medicine · 2019 · 75 citations · Full text

Antisense oligonucleotides targeting lncRNA AC104041.1 induces antitumor activity through Wnt2B/β-catenin pathway in head and neck squamous cell carcinomas

Mengwei Li, Xu Ding, Yinan Zhang et al. · Cell Death and Disease · 2020 · 71 citations · Full text

Micropeptide MIAC Inhibits HNSCC Progression by Interacting with Aquaporin 2

Mengwei Li, Xin Li, Yinan Zhang et al. · Journal of the American Chemical Society · 2020 · 61 citations

Rows per page

1–5 of 12